• Healthcare professionals are pivotal in assessing the risk of patients having metabolic associated fatty liver disease (MAFLD) and its link with metabolic disease progression
• What indicators to look out for, given fatty liver can occur in the absence of raised transaminases
• The importance of using calculators like the Fib4, when to ask a patient to have a fibrous scan, interpretation of results and when to refer to a specialist
• Consensus guidelines on MAFLD expected later in 2024, and what learning courses to consider

 

Host: Dr David Lim | Total Time: 25 mins

Expert: Prof Simone Strasser, Hepatologist

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.